The
Consortium for Neuropsychiatric Phenomics (CNP) advances the
NIH Roadmap Initiative by assembling a transdisciplinary “research
team of the future” to address major unsolved challenges
in research on neuropsychiatric disorders. The CNP leverages
the new discipline of phenomics – the systematic study
of phenotypes on a genome-wide scale – by integrating basic,
clinical and information sciences. Neuropsychiatric disorders
have enormous public health significance, and there is currently
a broad chasm between the basic and clinical research strategies
used to study these disorders. The CNP breaks down artificial
boundaries between psychiatric syndromes by studying important
neuropsychological phenotypes that cut across diagnostic groups,
and bridges basic and clinical sciences by studying these phenotypes
across different species. The ultimate goals of the CNP are to
facilitate discovery of the genetic and environmental bases of
variation in psychological and neural system phenotypes, to elucidate
the mechanisms that link the human genome to complex psychological
syndromes, and to foster breakthroughs in the development of
novel treatments for neuropsychiatric disorders. |
 |
Vertical 7-Level
Schema for the Consortium for Neuropsychiatric Phenomics |
|
|